Product gold-nanoparticles-custom-nanocomposites

Home > products > gold-nanoparticles> custom-nanocomposites

Catalog	name	Description	price
R-LCS04	MnO2 nanoparticle	Nano MnO2 has better electrical, magnetic, and catalytic properties than traditional manganese dioxide materials, making it potentially valuable in various fields such as environmental protection materials and biosensors.	price>
R-LCS05	Black phosphorus nanosheets	Nanoscale black phosphorus has a folded structure and a double-layer structure along the Z-shaped direction, which gives black phosphorus a higher specific surface area due to its folded structure. In addition, black phosphorus nanosheets also have good carrier mobility, making them widely used in electronic and optoelectronic devices.	price>
R-LCS17	Liposome loaded curcumin (about 100-200nm)	The commonly used curcumin lipid carrier is to wrap curcumin particles on the surface of lipid particles to form a spherical or spherical carrier, which can improve the degree of dispersion of curcumin, prolong the drug action time (sustained release effect), and increase biocompatibility	price>
R-LCS22	Hollow mesoporous silica nanoparticles (100-200nm) cross-linked with 8 polyarginine	Under alkaline conditions, the polymer-silica composite nanoparticles with a core-shell structure are obtained by hydrolyzing the silicon source, and then the template is removed by calcination to obtain mesoporous silica nanoparticles with a hollow structure.	price>
R-LCS26	HA-Dopamine	Dopamine-modified hyaluronic acid (DA-HA) has been initially developed as an efficient coating and adhesion material for industrial uses. Study proposes that Dopamine-modified hyaluronic acid (DA-HA) with DA-like functionalities and minimal toxicity has a great potential to treat DA-related disease.	price>
R-M1-cs8781	T-PEGCG-Zn2++Tetracycline Hydrochloride	The purpose of incorporating Tetracycline Hydrochloride into T-PEGCG-Zn2+ is to take advantage of the carrier system properties, such as enhanced stability, improved drug delivery, or targeted release. The complex may have the potential for controlled drug release, increased solubility, protection against degradation, or targeted delivery of Tetracycline Hydrochloride to specific sites in the body.T-PEGCG-Zn2+ is a combination of T, which typically represents the targeting ligand or peptide, PEGCG, which refers to polyethylene glycol grafted catechin gallate, and Zn2+, which represents the zinc ions.	price>
R-M1-cs8802	Surface modification of PEG2000 with doxorubicin liposomes(80-100nm)	Surface modification of PEG2000 with doxorubicin liposomes involves the attachment of polyethylene glycol chains onto the surface of liposomes loaded with the anticancer drug doxorubicin. (PEGylation)the process of attaching PEG chains is commonly employed in drug delivery systems to improve the stability, circulation time and biodistribution of liposomes. By coating liposomes with PEG, the system gains a protective layer that reduces opsonization and recognition by the immune system, thus extending the liposomes circulation time in the bloodstream.	price>
R-M1-8803	Cholesterol-PEG2000-mal-cys-WQPDTAHHWATL-K-FAM	Cholesterol-PEG2000-mal-cys-WQPDTAHHWATL-K-FAM/Cholesterol-PEG2k-maleimide-cysteine-WQPDTAHHWATL-K--FAM is a peptide sequence with improved stability, solubility, and target specificity, while also enabling fluorescence detection. FAM stands for fluorescein amidite, which is a fluorescent dye commonly used for labeling and detection purposes. It enables the visualization or tracking of the modified peptide sequence.	price>
R-M1-cs8804	Liposome encapsulated GFP protein(without saponins)	Liposome encapsulated GFP protein refers to the encapsulation of green fluorescent protein (GFP) within liposomes without the use of saponins.The resulting liposome-encapsulated GFP protein can be used in various applications, including fluorescence imaging, bioassays, biosensors, and studying protein-protein interactions. It provides a versatile tool to investigate cellular processes and analyze protein dynamics within a synthetic lipid environment.	price>
R-M1-8805	Liposome encapsulated GFP protein (containing saponins)	Liposome encapsulated GFP protein containing saponins refers to the process of incorporating the green fluorescent protein (GFP) into liposomes using saponins as membrane-disrupting agents.Liposome encapsulated GFP protein (containing saponins) can be utilized in various applications, including fluorescence imaging, protein delivery, and drug delivery systems. The use of saponins can enhance the encapsulation efficiency and stability of the GFP protein within the liposomes and facilitate its release at the desired site of action.	price>

...